Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram L Jacobs

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Virology|July 29, 2016
Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virusWilliam D Arndt, Stacy D White, Brian P Johnson, et al.
Virology|May 2, 2017
A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particlesLydia R Meador, Sarah A Kessans, Jacquelyn Kilbourne, et al.
Antiviral Research|July 1, 2009
Vaccinia virus vaccines: past, present and futureBertram L Jacobs, Jeffrey O Langland, Karen V Kibler, et al.
Plos One|March 20, 2012
In vitro characterization of a nineteenth-century therapy for smallpoxWilliam Arndt, Chandra Mitnik, Karen L Denzler, et al.
Nature Methods|June 18, 2013
Genome-wide profiling of human cap-independent translation-enhancing elementsBrian P Wellensiek, Andrew C Larsen, Bret Stephens, et al.
Vaccines|July 27, 2022
Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501Y<sub>MA30</sub> Strain of SARS-CoV-2Karen V Kibler, Mateusz Szczerba, Douglas Lake, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2021
Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501Y <sub>MA30</sub> strain of SARS-CoV-2Karen V Kibler, Mateusz Szczerba, Douglas Lake, et al.
Plos One|October 23, 2013
Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia virusesSusan A Holechek, Karen L Denzler, Michael C Heck, et al.
Virology|November 6, 2003
Genomic sequence of a ranavirus (family Iridoviridae) associated with salamander mortalities in North AmericaJames K Jancovich, Jinghe Mao, V Gregory Chinchar, et al.
The Journal of General Virology|February 11, 2015
Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1Petra Mooij, Gerrit Koopman, Jan Wouter Drijfhout, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Virology|July 29, 2016
Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virusWilliam D Arndt, Stacy D White, Brian P Johnson, et al.
Virology|May 2, 2017
A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particlesLydia R Meador, Sarah A Kessans, Jacquelyn Kilbourne, et al.
Antiviral Research|July 1, 2009
Vaccinia virus vaccines: past, present and futureBertram L Jacobs, Jeffrey O Langland, Karen V Kibler, et al.
Plos One|March 20, 2012
In vitro characterization of a nineteenth-century therapy for smallpoxWilliam Arndt, Chandra Mitnik, Karen L Denzler, et al.
Nature Methods|June 18, 2013
Genome-wide profiling of human cap-independent translation-enhancing elementsBrian P Wellensiek, Andrew C Larsen, Bret Stephens, et al.
Vaccines|July 27, 2022
Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501Y<sub>MA30</sub> Strain of SARS-CoV-2Karen V Kibler, Mateusz Szczerba, Douglas Lake, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2021
Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501Y <sub>MA30</sub> strain of SARS-CoV-2Karen V Kibler, Mateusz Szczerba, Douglas Lake, et al.
Plos One|October 23, 2013
Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia virusesSusan A Holechek, Karen L Denzler, Michael C Heck, et al.
Virology|November 6, 2003
Genomic sequence of a ranavirus (family Iridoviridae) associated with salamander mortalities in North AmericaJames K Jancovich, Jinghe Mao, V Gregory Chinchar, et al.
The Journal of General Virology|February 11, 2015
Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1Petra Mooij, Gerrit Koopman, Jan Wouter Drijfhout, et al.
Pageof 6